Replimune Group, Inc. Quarterly Nonoperating Income (Expense) in USD from Q2 2017 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Replimune Group, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q2 2017 to Q2 2024.
  • Replimune Group, Inc. Nonoperating Income (Expense) for the quarter ending June 30, 2024 was $3.6M, a 42.9% decline year-over-year.
  • Replimune Group, Inc. Nonoperating Income (Expense) for the twelve months ending June 30, 2024 was $16.7M, a 55.2% increase year-over-year.
  • Replimune Group, Inc. annual Nonoperating Income (Expense) for 2023 was $19.4M, a 529% increase from 2022.
  • Replimune Group, Inc. annual Nonoperating Income (Expense) for 2022 was $3.08M, a 1009% increase from 2021.
  • Replimune Group, Inc. annual Nonoperating Income (Expense) for 2021 was $278K.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $16.7M $3.6M -$2.7M -42.9% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $19.4M $3.61M -$430K -10.6% Jan 1, 2024 Mar 31, 2024 10-K 2024-05-16
Q4 2023 $19.8M $5.89M +$3.95M +204% Oct 1, 2023 Dec 31, 2023 10-Q 2024-02-08
Q3 2023 $15.9M $3.59M +$5.11M Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-07
Q2 2023 $10.8M $6.29M +$7.67M Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 $3.08M $4.04M +$3.75M +1285% Jan 1, 2023 Mar 31, 2023 10-K 2024-05-16
Q4 2022 -$668K $1.94M +$1.92M +7983% Oct 1, 2022 Dec 31, 2022 10-Q 2024-02-08
Q3 2022 -$2.58M -$1.52M -$1.42M -1310% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 -$1.17M -$1.38M -$1.45M -2067% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-03
Q1 2022 $278K $292K -$393K -57.4% Jan 1, 2022 Mar 31, 2022 10-K 2023-05-18
Q4 2021 $671K $24K +$1.53M Oct 1, 2021 Dec 31, 2021 10-Q 2023-02-09
Q3 2021 -$861K -$108K +$324K +75% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 -$1.19M $70K -$270K -79.4% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 -$915K $685K +$89K +14.9% Jan 1, 2021 Mar 31, 2021 10-K 2022-05-19
Q4 2020 -$1M -$1.51M -$1.98M -417% Oct 1, 2020 Dec 31, 2020 10-Q 2022-02-03
Q3 2020 $979K -$432K -$1.54M -139% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 $2.51M $340K -$1.06M -75.7% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-06
Q1 2020 $3.57M $596K -$574K -49.1% Jan 1, 2020 Mar 31, 2020 10-K 2021-05-20
Q4 2019 $4.15M $475K -$1.99M -80.7% Oct 1, 2019 Dec 31, 2019 10-Q 2021-02-04
Q3 2019 $6.14M $1.1M +$460K +71.5% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 $5.68M $1.4M +$5.56M Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-07
Q1 2019 $112K $1.17M +$1.24M Jan 1, 2019 Mar 31, 2019 10-K 2020-06-03
Q4 2018 -$1.13M $2.46M +$2.09M +552% Oct 1, 2018 Dec 31, 2018 10-Q 2020-02-13
Q3 2018 -$3.22M $643K +$1.05M Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 -$4.26M -$4.17M -$3.79M -1008% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-14
Q1 2018 -$473K -$71K Jan 1, 2018 Mar 31, 2018 10-K 2020-06-03
Q4 2017 $378K Oct 1, 2017 Dec 31, 2017 10-Q 2019-02-14
Q3 2017 -$404K Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-14
Q2 2017 -$376K Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.